Amplitude of low-frequency fluctuation after a single-trigger pain in patients with classical trigeminal neuralgia [0.03%]
经典三叉神经痛患者单一触发痛后的低频波动幅度变化
Xiuhong Ge,Luoyu Wang,Lei Pan et al.
Xiuhong Ge et al.
Objective: This study aimed to explore the central mechanism of classical trigeminal neuralgia (CTN) by analyzing the static amplitude of low-frequency fluctuation (sALFF) and dynamic amplitude of low-frequency fluctuatio...
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis [0.03%]
偏头痛预防治疗失败患者的降钙素基因相关肽或其受体单克隆抗体的疗效和安全性：网络meta分析
Xing Wang,Dingke Wen,Qiang He et al.
Xing Wang et al.
Objective: The relative effects of monoclonal antibody against calcitonin gene-related peptide (CGRP) or its receptor for adult migraine patients with prior treatment failure remains uncertain. Therefore, this study syste...
Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications [0.03%]
关于偏头痛生物-心理-社会模型应用的更正：合理性及临床意义
Chiara Rosignoli,Rafaele Ornello,Agnese Onofri et al.
Chiara Rosignoli et al.
Published Erratum
The journal of headache and pain. 2022 Sep 7;23(1):116. DOI:10.1186/s10194-022-01487-9 2022
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study [0.03%]
Eptinezumab治疗慢性偏头痛患者急性期止痛药使用量的变化：对PROMISE-2研究的亚组分析
Robert P Cowan,Michael J Marmura,Hans-Christoph Diener et al.
Robert P Cowan et al.
Background: Patients with chronic migraine (CM) treated with eptinezumab in the PROMISE-2 trial achieved greater reductions in migraine and headache frequency, impact, and acute headache medication (AHM) use than did pati...
Randomized Controlled Trial
The journal of headache and pain. 2022 Sep 6;23(1):115. DOI:10.1186/s10194-022-01482-0 2022
Long term evaluation of a multidisciplinary trigeminal neuralgia service [0.03%]
三叉神经痛多学科联合门诊的长期疗效评估
Sanjeet Singhota,Nana Tchantchaleishvili,Jianhua Wu et al.
Sanjeet Singhota et al.
Background: Trigeminal neuralgia is an episodic severe neuralgic pain and can be managed both medically and surgically. If possible, this should be directed by a Multidisciplinary Team (MDT) of specialised surgeons, physi...
Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress [0.03%]
偏头痛患者外周血单个核细胞中疾病和头痛特异性microRNA标志物及其在炎症信号传导和氧化应激中的作用
Timea Aczél,Bettina Benczik,Bence Ágg et al.
Timea Aczél et al.
Background: Migraine is a primary headache with genetic susceptibility, but the pathophysiological mechanisms are poorly understood, and it remains an unmet medical need. Earlier we demonstrated significant differences in...
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies [0.03%]
法拉奈珠单抗对发作性及慢性 migrainepatients病残 outcome影响的分析研究
Peter McAllister,Joshua M Cohen,Verena Ramirez Campos et al.
Peter McAllister et al.
Background: Migraine is the second leading cause of disability worldwide. Although many preventive treatments reduce migraine frequency and severity, it is unclear whether these treatments reduce migraine-related disabili...
Jennifer L Nguyen,Kiraat Munshi,Samuel K Peasah et al.
Jennifer L Nguyen et al.
Objective: This study examines changes in utilization and costs trends associated with migraine medications. Background: Migraine attac...
Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities [0.03%]
无精神病共病的偏头痛患者的行為和心理因素
Francesca Pistoia,Federico Salfi,Gennaro Saporito et al.
Francesca Pistoia et al.
Background: It is well known that the course of migraine is influenced by comorbidities and that individual psychological characteristics may impact on the disease. Proper identification of psychological factors that are ...
Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study [0.03%]
一项针对原发性头痛儿童和青少年的跨学科综合治疗项目的功能改善：DreKiP研究
Hanna Sobe,Matthias Richter,Reinhard Berner et al.
Hanna Sobe et al.
Background: More than 2/3 of children and adolescents in Germany regularly suffer from headaches. Headache-related limitations in everyday life, school drop-out and educational impairment are common. Structured therapy pr...